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Abstract
Background: We have recently shown that δ-opioid receptors (DORs) play an important role in
neuroprotection from hypoxic injury via the regulation of extracellular signaling-regulated kinase
(ERK) and cytochrome c release. Since ERK and cytochrome c are differentially involved in caspase
signaling of oxidative injury that significantly contributes to neuronal damage in ischemia/
reperfusion, we considered if DOR activation protects the ischemic brain by attenuating oxidative
injury.
Results: We observed that, in a model of cerebral ischemia with middle cerebral artery occlusion,
DOR activation increased the activity of major antioxidant enzymes, glutathione peroxidase and
superoxide dismutase, and decreased malondialdehyde and nitric oxide levels in the cortex
exposed to cerebral ischemia/reperfusion. In addition, DOR activation reduced caspase 3
expression, though it did not significantly affect the increase in interleukin (IL)1β and tumor
necrosis factor (TNF)α expression at the same timepoint. PD98059, an inhibitor of mitogen-
activated protein kinase (MAPK) extracellular signaling-regulated kinase kinase, accelerated animal
death during ischemia/reperfusion.
Conclusion:  DOR activation attenuates oxidative injury in the brain exposed to ischemia/
reperfusion by enhancing antioxidant ability and inhibiting caspase activity, which provides novel
insights into the mechanism of DOR neuroprotection.
Background
Stroke induces hypoxic injury in the brain and is a leading
cause of neurological disability and death in the world.
Although prevention and early treatment of this condition
are critical to reduce the devastating effects on individuals
and their families, to date there has been no effective strat-
egy to protect the brain from ischemic injury. Exploring
the complex mechanisms of hypoxic/ischemic injury and
finding new approaches against such injury have been a
long-term battle and attracted much attention from both
scientists and clinicians [1,2].
Our initial work found that activation of δ-opioid recep-
tors (DORs) are protective against hypoxic/excitotoxic
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injury in cortical neurons [3-5]. Furthermore, we observed
that DORs are involved in neuroprotection against
hypoxic/ischemic insults in various models including
neurons under hypoxia, brain slices exposed to hypoxia or
oxygen-glucose deprivation and in vivo brain with cerebral
ischemia [6-13]. More recently, substantial data generated
from other independent laboratories has demonstrated
that DORs are indeed neuroprotective against hypoxic or
ischemic stress, either in in vitro neurons or in vivo models
of brain or spinal ischemia [14-23]. For example, a recent
study [18] elucidated the effect of [D-Ala2,  D-Leu5]-
enkephalinamide (DADLE, a DOR agonist) on hippoc-
ampal neurons in ischemia and found that intraperito-
neal injection of DADLE improved hippocampal
neuronal survival in Sprague-Dawley rats. In fact, DORs
may be tonically involved in neuroprotection [4,22]
through a Gi-dependent manner [22].
However, the mechanism underlying the DOR neuropro-
tection is not well understood. In an in vitro exploration,
we found that DORs upregulate the activity of extracellu-
lar signaling-regulated kinase (ERK) and reduce the
release of cytochrome c, thus protecting neurons from
hypoxic injury [6]. Since ERK and cytochrome c are differ-
entially involved in caspase signaling of oxidative injury
that significantly contributes to ischemia/reperfusion (I/
R) injury [24-26], we considered in this work the question
of whether DOR activation can enhance antioxidant abil-
ity and thus attenuate oxidative injury in the brain
exposed to I/R stress. For the purpose of comparison, we
also determined whether DADLE affects the expression of
some inflammatory cytokines such as interleukin (IL)1β
and tumor necrosis factor (TNF)α, which are known to
play a role in I/R injury [25-27].
Results
Our previous work and those of others have clearly dem-
onstrated that DOR activation with DADLE or other DOR
agonists attenuates hypoxic/ischemic injury in cortical
neurons and reduces ischemic infarction in the cortex [3-
23]. Since caspase activity plays a key role in apoptotic sig-
nal transduction and is a crucial indicator of ischemic
injury [25,28,29], we studied whether DOR activation
reduced caspase activity in the ischemic brain by examin-
ing caspase 3 expression using immunohistochemical
methods. To mimic cerebral I/R injury, the model of
stroke was established by performing MCAO in the rat as
described in the methods. Since all the cortices were sam-
pled for biochemical measurements, immunohistochem-
istry was performed in the hippocampi of the same
animals. Unsurprisingly, we observed that DOR activa-
tion with DADLE reduced the expression of caspase 3
induced by MCAO. As shown in Figure 1, for example,
there was little caspase 3 signal in the sham control slices,
while there were more caspase 3-positive cells in the I/R
group, which could be largely reduced by DOR activation
with DADLE.
Next, we investigated if DOR activation preserves the anti-
oxidant mechanism because the brain is extremely vulner-
able to free radical attack that occurs in ischemia/
reperfusion [24,25,30-32]. Since superoxide dismutase
(SOD) and glutathione peroxidase (GSH-Px) are the most
important enzymes to protect against oxidative stress in
the brain [24,25], we measured their activities in the cor-
tex among three groups. As shown in Figure 2B, I/R largely
decreased SOD activity from 204.3 ± 5.39 U/mg protein
in the control to 162.2 ± 5.91 U/mg protein in the I/R
group (P < 0.0001), while DOR activation with DADLE
significantly increased SOD activity by 22.5 U/mg protein
(P < 0.0001) in the ischemic cortex. By contrast, GSH-Px
activity showed a similar change in response to I/R and
DADLE treatment. I/R stress significantly decreased GSH-
Px activity by 23% (18.72 ± 0.89 U/mg protein in the I/R
group vs 24.31 ± 0.78 U/mg protein in the control, P <
0.0001), which was markedly reversed by DADLE (+ 3.50
U/mg protein over the level of the I/R group, P < 0.0001)
(Figure 2B). These data suggest that I/R stress impairs the
antioxidant mechanism, while DOR activation partially
restores it.
Since a reduction of antioxidant enzymes leads to an
increase in free radical products[24,25,30-32], especially
malondialdehyde (MDA) that damages membrane integ-
rity, we compared the changes in cortical MDA in all
groups. The results showed that I/R induced a 40%
increase in MDA (8.99 ± 0.41 nmol/mg protein in the I/R
group vs. 6.43 ± 0.44 nmol/mg protein in the sham con-
trol group, P < 0.0001), while DADLE treatment resulted
in a significant decrease in the content of MDA (-15.6%
vs. I/R alone, P < 0.05) (Figure 3A). These results were well
consistent with those of antioxidant enzymes, SOD and
GSH-Px.
To further ascertain the effect of DOR activation on the
antioxidant mechanism, we examined the changes in NO,
another critical free radical that causes brain injury in
ischemia/reperfusion [24,25]. The data showed that I/R
almost doubled the level of NO (2.07 ± 0.27 μmol/g pro-
tein in the I/R group vs. 1.16 ± 0.16 μmol/g protein in the
control, P < 0.0001). This large increase was greatly inhib-
ited by the treatment with DADLE (-29.8%, P < 0.0001),
lending further support for the DOR-mediated inhibition
of free radical production (Figure 3B).
In addition to oxidant free radicals, inflammatory
cytokines have been shown to play a role in ischemic
injury [25-27]. Therefore, we examined, by quantitative
real-time PCR, whether DADLE affects the expression of
IL1β and TNFα that are known to be involved in neuronalBMC Biology 2009, 7:55 http://www.biomedcentral.com/1741-7007/7/55
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response to ischemic stress [25-27]. The primer and probe
sequences used in this work are presented in Table 1. Our
results showed that the levels of both IL1β and TNFα
mRNAs tremendously increased after I/R stress (Figure 4).
Specifically, IL1β mRNA increased by more than 7-fold (P
= 0.001 vs. that of the control group) and TNFα mRNA,
>2.5-fold (P = 0.001 vs that of the control). However, the
treatment with DADLE did not induce a significant reduc-
tion in ischemic expression of IL1β and TNFα mRNAs at
this particular timepoint (72 h after MCAO), suggesting a
specific effect of DADLE on antioxidant enzymes and oxi-
dant free radicals shown in Figures 2 and 3.
Since our previous work has suggested that ERK activation
is neuroprotective and may mediate the DOR-induced
neuroprotection in cortical neurons [6], we further inves-
tigated if it is involved in the DOR-induced protection
from I/R injury. Therefore, we proposed to determine the
effect of ERK kinase inhibition on the ischemic brain by
applying PD98059, an ERK inhibitor, into the lateral ven-
tricle of the brain. Unfortunately, most of the animals (10
out of 12 rats), either with or without DADLE, died before
the timepoint (72 h after MCAO) set for biochemical or
molecular measurements. The death rate (>83%) was sig-
nificantly higher than that of all other groups. This obser-
vation suggests that the inhibition of ERK kinase greatly
exacerbated the I/R injury and increased animal death
rate.
Discussion
We have made two major findings in the cortex exposed
to cerebral ischemia and reperfusion: (1) DOR activation
partially reversed the I/R-induced decrease in SOD and
GSH-Px activity and (2) DOR activation decreased the
content of MDA and NO, suggesting that DOR activation
attenuates oxidative injury in the I/R brain. In addition,
we observed that the inhibitor of ERK kinase that medi-
ates DOR neuroprotection [6] accelerated the death of the
[D-Ala2, D-Leu5]-Enkephalinamide (DADLE)-induced reduction of caspase 3 staining in the hippocampus exposed to ischemia/ reperfusion (I/R) stress Figure 1
[D-Ala2, D-Leu5]-Enkephalinamide (DADLE)-induced reduction of caspase 3 staining in the hippocampus 
exposed to ischemia/reperfusion (I/R) stress. A, Representative images. Strept actividin-biotin complex (SABC), 10 × 40. 
(i) Sham I/R. (ii) I/R. (iii) I/R plus. Arrows indicate caspase 3-positive cells. Note that there was little caspase 3 staining in the 
sham control slice, while there was strong signal staining in that of I/R group, which was largely reduced by δ-opioid receptor 
(DOR) activation with DADLE. B, Quantification of caspase 3-positive cells. Mean ± standard error (n = 6). *, P < 0.05, I/R or 
I/R + DADLE versus control. #, P < 0.05, I/R + DADLE versus I/R. Note that the administration of DADLE reduced the 
number of caspase 3-positive cells in the hippocampus following the cerebral ischemia/reperfusion.BMC Biology 2009, 7:55 http://www.biomedcentral.com/1741-7007/7/55
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I/R animals, while DOR activation reduced the produc-
tion of caspase 3 that triggers neuronal death [25,28,29].
This is the first study showing that DOR activation
increases SOD and GSH-Px activity in the brain exposed
to ischemia/reperfusion. Neuronal function is dependent
on the integrated dynamics of the membrane lipid matrix,
which is vulnerable to free radical attack due to ischemic/
oxidative stress [24,25,30-32]. Free radicals are com-
pounds possessing an unpaired electron, which renders
them highly reactive and capable of causing oxidative
damage to all the major macromolecules, including lip-
ids, proteins and nucleic acids in cells. A major family of
free radicals is the reactive oxygen species (ROS) and
another important free radical is NO [25,30-34]. In nor-
mal circumstances, the brain is protected from free radical
attack by antioxidant mechanisms that include antioxi-
dant enzymes (for example, SOD and GSH-Px) and free
radical scavenging substances (for example, ascorbate,
vitamin E and protein sulfhydryls) [24,25,30-34]. Lack of
oxygen and/or blood supply in relation to aerobic ATP
requirements and oxygen/blood reperfusion cause an
[D-Ala2, D-Leu5]-Enkephalinamide (DADLE)-induced increase  in superoxide dismutase (SOD) (top panel) and glutathione  peroxidase (GSH-Px) (bottom panel) activities of the cortex  exposed to ischemia/reperfusion (I/R) stress Figure 2
[D-Ala2, D-Leu5]-Enkephalinamide (DADLE)-induced 
increase in superoxide dismutase (SOD) and glutath-
ione peroxidase (GSH-Px)  activities of the cortex 
exposed to ischemia/reperfusion (I/R) stress. Mean ± 
standard deviation (n = 6). * P < 0.05 versus the control 
group. #P < 0.05 versus I/R group. Note that I/R induced a 
significant reduction of SOD and GSH-Px activities, which 
were increased by δ-opioid receptor (DOR) activation with 
DADLE treatment.
[D-Ala2, D-Leu5]-Enkephalinamide (DADLE)-induced  decrease in malondialdehyde (MDA) and NO in the cortex  exposed to ischemia/reperfusion (I/R) stress Figure 3
[D-Ala2, D-Leu5]-Enkephalinamide (DADLE)-induced 
decrease in malondialdehyde (MDA) and NO in the 
cortex exposed to ischemia/reperfusion (I/R) stress. * 
P < 0.05 versus the control group. #P < 0.05 versus I/R 
group. Note that I/R stress largely increased the contents of 
MDA and NO in the cortex by 40% to 100%, which was sig-
nificantly reduced by δ-opioid receptor (DOR) activation 
with DADLE.
Table 1: Primers and probes
Sequences of primers and probes
β-Actin Forward primer: 5'-acggccaggtcactattg-3'
Reverse primer: 5'-caagaaggaaggctggaaaaga-3'
Probe: 5'-FAM-caacgagcggttccgatgccct-TAMRA-3'
IL1β Forward primer: 5'-gatgaaagacggcacacc-3'
Reverse primer: 5'-ctatgtcccgaccattgc-3'
Probe: 5'-FAM-aagcggtttgtcttcaacaag-TAMRA-3'
TNFα Forward primer: 5'-gtgttcatccgttctctaccc-3'
Reverse primer: 5'-gccacaattccctttctaagtt-3'
Probe: 5'-FAM-acccctttatcgtctactcctcagagccc-TAMRA-3'
FAM = 6-carboxyfluorescin;
IL = interleukin;
TAMRA = 6-carboxytetramethylrhodamine;
TNF = tumor necrosis factor.BMC Biology 2009, 7:55 http://www.biomedcentral.com/1741-7007/7/55
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increase in the generation of ROS and NO. Oxidative
injury occurs when the production of free radicals is
greater than the ability of the cell to repair the resulting
damage [24,25,30-33]. Ischemic/hypoxic injury may be
intensified by concurrent oxidative injury. Polyunsatu-
rated fatty acids (PUFAs) are among the molecules most
susceptible to ROS. The oxidative breakdown of mem-
brane PUFAs yields toxic MDA, which compromises not
only membrane lipid matrix dynamics, and hence struc-
ture and function of membrane-associated proteins such
as enzymes, receptors, and transporters, but also gene
expression [24,25,32]. By contrast, excessive NO leads to
the release of cytochrome c from the mitochondria and
triggers cellular death through caspase pathway [25,33].
Indeed, we observed a large decrease in antioxidant
enzymes with a marked increase in MDA and NO in the
ischemic brain. Such changes could injure the brain with-
out doubt. Interestingly, our present data suggest that
these pathophysiological changes could be partially
reversed by DOR activation. This finding may provide a
clue for new strategies against hypoxic/ischemic brain
injury.
Caspases are synthesized in most cells, including neurons,
as inactive precursors, with caspase 3 being a terminal
enzyme in the caspase family that activates an endonucle-
ase (caspase-activated DNAse), resulting in DNA fragmen-
tation and neuronal death in ischemia [25,28,29]. Since
DOR activation inhibits the production of NO in the
ischemic brain, it was not a surprise to see a decrease in
caspase 3 expression in our study. NO, a water and lipid-
soluble free radical, is an inorganic gas that has an
extremely short half-life. This unstable nitrogen radical
plays an important role in the control of cerebral blood
flow and thrombogenesis and modulation of neuronal
activity. However, I/R stress may stimulate NO synthase
and result in excessive amounts of NO in the brain. Exces-
sive production of NO causes cytochrome c release from
the mitochondria and activates caspase signal pathway,
thus triggering neuronal death through the caspase-acti-
vated DNase activation [25,34]. In our previous study, we
have observed that DOR activation attenuated cyto-
chrome  c  release in severe hypoxic stress [6]. Taken
together with the present results, it is likely that DOR acti-
vation may reduce the production of NO, attenuate cyto-
chrome  c  release and decrease caspase activity, thus
protecting the brain from ischemia/reperfusion injury.
In our previous exploration of the mechanism underlying
DOR neuroprotection, we showed that ERK is involved in
the DOR signaling in neuroprotection [6]. Subsequently,
another independent laboratory also demonstrated that
ERK signaling plays an important role in DOR-mediated
neuroprotection [17]. However, both our and other stud-
ies were conducted in in vitro models [6,17]. It is unclear
whether ERK mediates DOR neuroprotection in the in vivo
model, especially in the ischemic brain. We therefore pro-
posed to address this issue in this work. Unfortunately,
most animals died after microinjection of ERK inhibitor
into the ventricle, even with DADLE treatment. This jeop-
ardized our further studies on these animals. However,
such an outcome does provide hints implying that ERK,
consistent with our previous finding [6], is in a key posi-
tion in an intracellular pathway mediating DOR neuro-
protection because (1) the blockade of ERK exacerbated
ischemia/reperfusion injury and (2) DOR activation
could not protect the animals from ischemia/reperfusion
injury after the blockade of ERK in the brain.
The data on IL1β and TNFα mRNA expression suggest that
the effect of DOR activation on oxidative injury is specific
in this work. However, we cannot rule out the possibility
that DOR signals may target proinflammatory cytokines
after I/R stress since many cellular and molecular mecha-
nisms function differently at various stages of pathophys-
Effect of [D-Ala2, D-Leu5]-enkephalinamide (DADLE) on  tumor necrosis factor (TNF)α and interleukin (IL)1β mRNA  expression of the cortex exposed to ischemia/reperfusion (I/ R) stress Figure 4
Effect of [D-Ala2, D-Leu5]-enkephalinamide (DADLE) 
on tumor necrosis factor (TNF)α and interleukin 
(IL)1β mRNA expression of the cortex exposed to 
ischemia/reperfusion (I/R) stress. Mean ± standard devi-
ation (n = 6). * P < 0.05 versus the control group. #P > 0.05 
versus I/R group. Note that the cerebral I/R dramatically 
increased the levels of TNFα and IL1β mRNA by 350% to 
700%.BMC Biology 2009, 7:55 http://www.biomedcentral.com/1741-7007/7/55
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iological events. It is essential to perform more studies at
different timepoints along the course of such events to
draw solid conclusions as to whether DOR activation has
any effect on inflammatory response to ischemia/reper-
fusion.
Conclusion
We have elucidated the mechanism of DOR protection
from cerebral ischemia by investigating the effect of DOR
activation on antioxidant mechanisms in the brain
exposed to ischemia and reperfusion. Our data show that
DOR activation greatly enhances the activity of antioxi-
dant enzymes and reduces free radicals, MDA and NO, in
the brain after cerebral ischemia and reperfusion. The
results suggest that DOR activation attenuates oxidative
injury, which may be one of the important mechanisms
underlying DOR protection from ischemic injury
[5,12,16,18-21]. Taken together with our previous stud-
ies, the potential mechanism of DOR neuroprotection
from I/R injury is schematically demonstrated (Figure 5).
Methods
Animals
Adult male Sprague-Dawley rats weighing 250 to 270 g
were purchased from the Experimental Animal Center of
Soochow University (Suzhou, Jiangsu, China). Animals
were housed in a room with temperature of 21 to 23°C,
relative humidity at 30% to 70%, and a 12-h light/12-h
dark cycle. They had free access to food and water. All
experimental procedures in this study were performed in
accordance with the guidelines for the care and use of lab-
oratory animals of Soochow University.
Experimental groups
The rats, under deep anesthesia, were exposed to cerebral
ischemia (see below) for 2 h followed by 72-h reperfusion
to induce I/R injury in the brain. We have previously
shown DOR activation induced protection from ischemic
injury [5,12]. Since this study was mainly for the purpose
of determining if DOR activation has any effect on major
antioxidant enzymes and oxidant free radicals after I/R,
we randomly assigned the animals to various groups after
the same procedure for cerebral ischemia (see below), and
sampled cortical and hippocampal tissues for biochemi-
cal and molecular measurements. The animals that died
before the timepoint (72 h after MACO) were removed
from the experiments, since no brain tissues could be
sampled from them. There was no significant change in
the death rate among various groups except for the
PD98059 group (see below and Results).
In the I/R plus DOR activation group (n = 12), the I/R rats
were treated with DADLE, a DOR agonist purchased from
Sigma (St Louis, MO, USA). DADLE was applied through
intraperitoneal injection (1 mg/kg in saline) [18] within
30 min starting at 30 min after the onset of suture occlu-
sion. The reason we chose to apply DADLE in the early
stage of ischemia was because an early application of
DADLE displays better neuroprotection against excito-
toxic injury, as shown in our previous work [3]. In the I/R
control group (n = 12), the procedures were the same
except for vehicle solution without DADLE. In the sham
control group (n = 6), rats were subjected to sham I/R
operation. In addition, in a group of rats (n = 12),
PD98059 (Sigma, St Louis, MO, USA; 1 μg in 6 μl of vehi-
cle solution), a specific inhibitor of mitogen-activated
protein kinase (MAPK) extracellular signaling-regulated
kinase (ERK) kinase, was microinjected into the right lat-
eral ventricle of the ischemic rats with or without DADLE,
through a stereotaxically inserted 27-gauge needle
(ALCB10, Shanghai Alcott Biotech, Shanghai, China) (1.5
mm lateral and 1 mm posterior to the bregma, 4 mm in
depth) [35]. The microinjection was started at 30 min
after the onset of cerebral ischemia and was completed
within 30 min. After the microinjection, sterile procedures
were performed to suture the skin.
Induction of cerebral ischemia
To mimic cerebral I/R injury, the model of stroke was
established by performing MCAO in the rat [5,12,36]. In
brief, rectal temperature was recorded and maintained at
37°C ± 0.5°C throughout the surgical procedure and up
to 2 h after reperfusion. The right common carotid artery
was carefully separated from around tissues and a 4-0
monofilament nylon suture coated with paraffin was
inserted through the external carotid artery stump into the
internal carotid artery to occlude the right middle cerebral
artery. After 2 h of occlusion, the nylon monofilament
Schematic diagram showing potential mechanism of δ-opioid  receptor (DOR) protection from oxidative injury in the brain  exposed ischemia/reperfusion Figure 5
Schematic diagram showing potential mechanism of 
δ-opioid receptor (DOR) protection from oxidative 
injury in the brain exposed ischemia/reperfusion.BMC Biology 2009, 7:55 http://www.biomedcentral.com/1741-7007/7/55
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suture was withdrawn for blood flow reperfusion. In the
sham-operated group, the surgical procedures were the
same as in the ischemic animals except for real insertion
of the suture.
Sample preparation
After 72-h reperfusion, the rat brains were quickly
removed under deep anesthesia and placed into cold eth-
ylenediaminetetraacetic acid (EDTA) buffer (0.02 M, pH =
7.4) for removing tissue debris and blood clots. All visible
vascular structures were also removed. Then, the cortex
and hippocampus were dissected from the hemispheres,
respectively.
For immunohistochemistry, the tissues were fixed in 10%
formalin, pH 7.4. After dehydration in graded ethanol
and xylene, the tissues were paraffin embedded and cut
into coronal sections (4 μm thick). For RNA and other
measurements, the samples were frozen in liquid nitrogen
and stored at -80°C until use.
For detection of the activities of antioxidant enzymes
(SOD and GSH-Px) and the content of MDA and nitric
oxide (NO), the tissue samples were weighed and homog-
enized with a buffer consisting of 10 mM sucrose, 10 mM
tris(hydroxymethyl)aminomethane (Tris)-HCl, and 0.1
mM EDTA (pH 7.4), and then centrifuged at 3,000 g for
15 min at 4°C. The supernatant was used for bioassays.
Total protein concentration was measured using the
method of bicinchoninic acid protein assay. All the data
were normalized to protein concentration (a unit value
per μg of protein).
Caspase 3 immunohistochemistry
Procedures were processed according to the manufac-
turer's protocol recommended for the caspase 3 immuno-
histochemistry kit (Beijing Zhongshan Biotechnology,
Beijing, China). Following deparaffinzation and rehydra-
tion, brain sections were irradiated in 0.1 mol/l sodium
citrate buffer (pH 6.0) in a microwave oven for 12 min.
The sections were then exposed to 3% H2O2 for 10 min to
bleach endogenous peroxidases, and subsequently sub-
jected to three rinses with phosphate-buffered saline
(PBS) for 10 min each. These sections were incubated with
an anti-caspase 3 primary antibody (1:100, Beijing
Zhongshan Biotechnology) for 1 h at 37°C and then
washed in PBS 3 times. Finally, the sections were incu-
bated with a biotinylated goat secondary anti-mouse anti-
body (Beijing Zhongshan Biotechnology) for 30 min at
37°C. The primary antibody was omitted in the control
sections. After washing in PBS, caspase 3 signals were vis-
ualized with 3,3'-diaminobenzidine tetrahydrochloride
(DAB) and counterstained with hematoxyline. Finally, the
sections were dehydrated in graded ethanol, immersed in
xylene and covered by cover slips.
The number of caspase 3-positive cells was blindly
counted by a researcher blinded to the assignment of
experimental groups. In brief, images were taken with an
Olympus BX-51 microscope (Olympus, Tokyo, Japan).
Cells with a blue color were counted as neurons. Cells
showing both blue and brown color were counted as cas-
pase 3-positive neurons. At least three view areas were ran-
domly selected for a given region on each section. The
ratio of caspase 3-positive cells per neurons in each view
area was calculated and then three or more values from
the randomly selected view areas were averaged to repre-
sent the value of the region.
Assay of SOD activity
SOD activity was measured using an assay kit from Nan-
jing Jiancheng Bioengineering Institute (Nanjing, China)
according to the manufacturer's protocol. It uses a xan-
thine-xanthine oxidase system to determine the inhibi-
tion of nitroblue tetrazolium (NBT) reduction due to
superoxide anion generation. Briefly, 500 μl of superna-
tant was mixed with 50 μM xanthine and 2.5 μM xanthine
oxidase in 50 μM potassium phosphate buffer and incu-
bated at 37°C for 40 min. Then, NBT is added. Total
nitrite (nitrite + nitrate) produced by the oxidation of
oxyamine was measured by detecting the absorbance at
550 nm. A unit of SOD was defined as the enzyme
amount causing 50% inhibition of the NBT reduction
rate. The SOD activity was expressed as units of nitrite per
mg protein.
Assay of GSH-Px activity
The GSH-Px activity was determined using an assay kit
from Nanjing Jiancheng Bioengineering Institute accord-
ing to the manufacturer's protocol. In brief, 200 μl of the
supernatant was mixed with 2.68 ml of 0.05 M phosphate
buffer (pH 7.0) containing 5 mM of EDTA, followed by
the addition of 0.1 ml of 8.4 mM nicotinamide adenine
dinucleotide phosphate (NADPH), 0.01 ml of glutath-
ione reductase, 0.01 ml of 1.125 M NaN2, and 0.1 ml of
0.15 M glutathione. The enzymatic reaction was initiated
by the addition of 0.1 ml of 2.2-mM H2O2. The changes
in absorbance at 340 nm were continuously recorded
between 2 and 4 min after initiation of the reaction (con-
verting NADPH to NADP). A GSH-Px unit was defined as
the enzyme activity required to convert 1 mmol of
NADPH to NADP per mg tissue protein. The GSH-Px
activity was expressed as units per mg protein.
MDA assay
The MDA content was determined by the thiobarbituric
acid method using an assay kit from Nanjing Jiancheng
Bioengineering Institute according to the manufacturer's
recommendations. It was assayed in the form of thiobar-
bituric acid reacting substances (TBARS). A total of 100 μl
of the supernatant was mixed with 1 ml of 20% trichloro-BMC Biology 2009, 7:55 http://www.biomedcentral.com/1741-7007/7/55
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acetic acid and 1.0 ml of 0.1% TBARS reagent and incu-
bated at 95°C for 80 min. After cooling on ice, the mixture
was centrifuged at 1,000 g for 20 min. The absorbance of
the supernatant was measured at 532 nm. The amount of
TBARS was determined using tetraethoxypropane as a
standard. The content of TBARS, as an index of MDA, was
expressed as nmol per mg protein.
Nitric oxide assay
The concentration of nitrite was measured to reflect the
production of NO using a Griess reagent system kit
(Jiancheng Institute of Biotechnology), according to the
manufacturer's recommendations. In brief, the superna-
tant was mixed with the Griess reagent (1% sulfanilamide,
0.1% N-l-naphathyletylenediamine dihydrochloride and
2.5% phosphoric acid) at room temperature for 10 min.
Nitrite products in the supernatants were determined by
measuring absorbance at 550 nm with NaNO2 being used
for a standard curve. The results were expressed as μmol/g
protein.
Quantitative real-time polymerase chain reaction (PCR)
Total RNA was extracted from the brain tissues with Trizol
reagent (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer's protocol and then reverse transcribed
using a RevertAid First Strand cDNA Synthesis kit (Fer-
mentas, Vilnius, Lithuania).
The cDNA sequences for IL1β, TNFα, and β-actin were
obtained from NCBI GenBank. Specific PCR primers and
TaqMan fluorogenic probes were designed using Primer
Express software (Applied Biosystems, Foster City, CA,
USA) and commercially synthesized by Invitrogen. 6-Car-
boxyfluorescin (6-FAM) was used as the reporter dye and
6-carboxytetramethylrhodamine (TAMRA) as the
quencher dye.
Real-time reverse transcriptase (RT)-PCR was performed
with TaqMan Universal PCR Master Mix (Applied Biosys-
tems) on a Lightcycle (Roche, Basel, Switzerland). Briefly,
the reaction mixture contained cDNA 2 μl, 10 × buffer 2.5
μl, 25 mM MgCl2 1.5 μl, 10 mM dNTP 0.5 μl, Taq 0.5 μl,
0.1 μl each of the 100 μM sense and antisense primers and
0.1 μl of 100 μM probe. All samples were tested in dupli-
cate. The conditions of amplification for TNFα were 95°C
for 2.5 min, 95°C for 5 s and 56°C for 45 s for 40 cycles.
The conditions of amplification for IL1β were 95°C for
2.5 min, 95°C for 15 s and 60°C for 45 s for 40 cycles. The
amplification for β-actin was performed according to the
manufacturer's instructions (Invitrogen).
The relative levels of these mRNAs were calculated by 2-
ΔΔCT method and the levels of TNFα and IL1β mRNAs were
normalized to that of β-actin.
Statistical analysis
All data were subjected to statistical analysis using Graph
Prism v. 5.0 software (GraphPad Software, San Diego, CA,
USA). Statistical significances among groups were deter-
mined by one-way analysis of variance (ANOVA) or
unpaired t test. P < 0.05 was considered as statistically sig-
nificant.
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